TY  - GEN
AU  - Connolly,Roisin M
AU  - Li,Huili
AU  - Jankowitz,Rachel C
AU  - Zhang,Zhe
AU  - Rudek,Michelle A
AU  - Jeter,Stacie C
AU  - Slater,Shannon A
AU  - Powers,Penny
AU  - Wolff,Antonio C
AU  - Fetting,John H
AU  - Brufsky,Adam
AU  - Piekarz,Richard
AU  - Ahuja,Nita
AU  - Laird,Peter W
AU  - Shen,Hui
AU  - Weisenberger,Daniel J
AU  - Cope,Leslie
AU  - Herman,James G
AU  - Somlo,George
AU  - Garcia,Agustin A
AU  - Jones,Peter A
AU  - Baylin,Stephen B
AU  - Davidson,Nancy E
AU  - Zahnow,Cynthia A
AU  - Stearns,Vered
TI  - Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study
SN  - 1557-3265
PY  - 2018///0316
KW  - Adult
KW  - Aged
KW  - Azacitidine
KW  - administration & dosage
KW  - Benzamides
KW  - Biomarkers, Tumor
KW  - blood
KW  - Combined Modality Therapy
KW  - Disease-Free Survival
KW  - Epigenesis, Genetic
KW  - genetics
KW  - Estrogen Receptor alpha
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - National Cancer Institute (U.S.)
KW  - Neoplasm Staging
KW  - Pyridines
KW  - Treatment Outcome
KW  - Triple Negative Breast Neoplasms
KW  - drug therapy
KW  - United States
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1158/1078-0432.CCR-16-1729
ER  -